Out-of-Pocket Costs for Tyrosine Kinase Inhibitors and Patient Outcomes in EGFR- and ALK-Positive Advanced Non–Small-Cell Lung Cancer Literature review identified 226 unique measures from 23 measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback